Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Berlin, Germany
Countries of investment
  • France
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Retail
  • Sustainability
About
Embryo Ventures is a Londonbased venture Capital firm dedicated to investing in transformative companies at the seed stage. Established with a focus on Health, Living, and Cities, the firm backs exceptional founders driven by purpose and bold visions. Embryo Ventures places a strong emphasis on the Sustainable development of health, environments, and living patterns. Notable investments include PLUVO, Cheeky Panda, Thermulon, NOVARA, TasteIndex, Calla Lily Clinical Care, LAKA, BioLumen, OSSTEC, STAXY, and OSTIQUE. The firm commits to being active partners with founders, providing value beyond Capital, and focusing on ventures that solve societal needs and drive positive, Sustainable transformations globally.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

They invest in the future of Health, Cities and Living. Our investments span products and platforms across consumer, industry and healthcare, with a focus in HealthTech, Materials, Frontier Tech, SustainableTech and SaaS.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

CaUnited Statesly

Unibuddy

Mentor Collective

Engageli

FutureFit AI

Morressier

Colossyan

FoondaMate

Junto

Sparkwise

Cadmus

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp